FSTRX
Price
$30.51
Change
-$0.87 (-2.77%)
Updated
Dec 18 closing price
RMEBX
Price
$54.53
Change
-$1.42 (-2.54%)
Updated
Dec 18 closing price
Ad is loading...

FSTRX vs RMEBX

Header iconFSTRX vs RMEBX Comparison
Open Charts FSTRX vs RMEBXBanner chart's image
Federated Hermes MDT Large Cap Value A
Price$30.51
Change-$0.87 (-2.77%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R2E
Price$54.53
Change-$1.42 (-2.54%)
VolumeN/A
CapitalizationN/A
FSTRX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSTRX vs. RMEBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTRX is a Hold and RMEBX is a Buy.

FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 98.7B vs. FSTRX (1.33B). RMEBX pays higher dividends than FSTRX: RMEBX (1.54) vs FSTRX (1.08). FSTRX was incepted earlier than RMEBX: FSTRX (11 years) vs RMEBX (10 years). FSTRX is a more actively managed with annual turnover of: 95.00 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than FSTRX: RMEBX (250) vs FSTRX (1500). RMEBX annual gain was more profitable for investors over the last year : 12.51 vs. FSTRX (11.12). RMEBX return over 5 years is better than : 39.44 vs. FSTRX (20.00).
FSTRXRMEBXFSTRX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years10 years-
Gain YTD9.85211.31387%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B98.7B1%
Annual Yield % from dividends1.081.5470%
Returns for 1 year11.1212.5189%
Returns for 3 years7.5313.7055%
Returns for 5 years20.0039.4451%
Returns for 10 years23.4660.5039%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATS31.130.19
+0.61%
ATS Corp
EVRI13.500.04
+0.30%
Everi Holdings
NTRS104.71-0.85
-0.81%
Northern Trust Corp
GLYC0.23-0.01
-2.83%
GlycoMimetics
LYEL0.65-0.02
-3.65%
Lyell Immunopharma